Szyguła-Jurkiewicz, B.; Szczurek-Wasilewicz, W.; Gąsior, M.; Copik, I.; Małyszek-Tumidajewicz, J.; Skrzypek, M.; Romuk, E.; Zembala, M.; Zembala, M.; Przybyłowski, P.
Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices. Antioxidants 2021, 10, 1813.
https://doi.org/10.3390/antiox10111813
AMA Style
Szyguła-Jurkiewicz B, Szczurek-Wasilewicz W, Gąsior M, Copik I, Małyszek-Tumidajewicz J, Skrzypek M, Romuk E, Zembala M, Zembala M, Przybyłowski P.
Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices. Antioxidants. 2021; 10(11):1813.
https://doi.org/10.3390/antiox10111813
Chicago/Turabian Style
Szyguła-Jurkiewicz, Bożena, Wioletta Szczurek-Wasilewicz, Mariusz Gąsior, Izabela Copik, Justyna Małyszek-Tumidajewicz, Michał Skrzypek, Ewa Romuk, Michał Zembala, Marian Zembala, and Piotr Przybyłowski.
2021. "Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices" Antioxidants 10, no. 11: 1813.
https://doi.org/10.3390/antiox10111813
APA Style
Szyguła-Jurkiewicz, B., Szczurek-Wasilewicz, W., Gąsior, M., Copik, I., Małyszek-Tumidajewicz, J., Skrzypek, M., Romuk, E., Zembala, M., Zembala, M., & Przybyłowski, P.
(2021). Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices. Antioxidants, 10(11), 1813.
https://doi.org/10.3390/antiox10111813
